Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05489159 · ClinicalTrials.gov registry record

Sleep and IR in Transgender Adolescents

A clinical trial, sponsored by Duke University.

Completed
Registry status
10
Enrollment target

NCT05489159 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05489159 has completed, sponsored by Duke University.

COMPLETED
Registry status
10 participants
Enrollment target

Study Summary

Disordered sleep is a health issue with significant impacts on physical and psychological well-being that has increased in prevalence, but its impact on transgender adolescents has not been fully quantified. While there is found to be an impact of sex steroids on sleep, and sex-dependent differences in the impact of sleep duration and quality on insulin resistance (IR), there is limited available information regarding the impact of Gender Affirming Hormone Therapy (GAHT) for transgender individuals on sleep and IR. Our study aims to quantify the impacts of GAHT on sleep and IR in the pediatric transgender population as well as determine the degree of correlation of sleep to IR in this population.

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-10-12
Est. Completion 2024-08-16

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05489159

The ClinicalTrials.gov registry entry for NCT05489159 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05489159 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05489159 about?

NCT05489159 is a clinical study titled "Sleep and IR in Transgender Adolescents". Disordered sleep is a health issue with significant impacts on physical and psychological well-being that has increased in prevalence, but its impact on transgender adolescents has not been fully quantified. While there is found to be an impact of sex steroids on sleep, and sex-dependent differences...

What is the current status of trial NCT05489159?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2022-10-12. Estimated completion is 2024-08-16.

Who is sponsoring clinical trial NCT05489159?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.